Год
2023
-
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients
-
Gilead buoyed by Trodelvy OK in new breast cancer use
-
Medicago to Shut Down Despite COVID-19 Vaccine Approval
-
US FDA approves Ellipses Pharma’s IND for AML therapy
-
ICER Questions Benefit of Fezolinetant for Hot Flashes
-
Jesduvroq (daprodustat) approved by US FDA for anaemia of chronic kidney disease in adults on dialysis
-
MHRA Approves Nubeqa Treatment Combination for Advanced Form of Prostate Cancer
-
NICE Recommends Epidyolex for Tuberous Sclerosis Complex Seizures
-
API Distributor LGM Pharma Enters Consent Decree
-
FDA Approves Sutimlimab-jome with Long-Term Safety, Efficacy Data for Cold Agglutinin Disease